Table 6.

The correlation between TNFAIP2 SNPs and gastric cancer (GC) prognosis in the general analysis.

TNFAIP2 SNPs	GC	Death	Median survival time (mean)	Univariate analysis		Multivariate analysis
				P-value	HR (95% CI)	P-value*	HR (95% CI)
rs8126	n = 287	n = 120
TT	137	58	56.4b
TC	109	44	79.0a	0.840	0.960 (0.649–1.421)	0.501	1.147 (0.770–1.707)
CC	41	18	68.0a	0.840	1.056 (0.622–1.792)	0.399	1.262 (0.735–2.165)
CC + TC vs. TT				0.932	1.008 (0.843–1.205)	0.408	1.166 (0.811–1.676)
CC vs. TC + TT				0.793	0.967 (0.753–1.242)	0.588	1.151 (0.692–1.915)
rs710100	n = 263	n = 111
CC	110	49	68.0a
TC	114	46	79.0a	0.468	1.161 (0.776–1.736)	0.349	0.824 (0.549–1.236)
TT	39	16	68.0a	0.513	1.099 (0.829–1.457)	0.638	0.871 (0.489–1.550)
TC + TT vs. CC				0.394	1.085 (0.899–1.309)	0.329	0.828 (0.567–1.209)
TT vs. CC + TC				0.643	1.065 (0.817–1.388)	0.713	0.904 (0.528–1.547)
rs3759571	n = 275	n = 113
GG	113	45	58.2b
GA	124	53	79.0a	0.685	0.921 (0.619–1.370)	0.803	0.950 (0.635–1.421)
AA	38	15	55.1b	0.951	1.009 (0.753–1.352)	0.325	0.739 (0.405–1.349)
GA + GG vs. AA				0.772	0.973 (0.806–1.174)	0.599	0.902 (0.614–1.324)
GG vs. GA + AA				0.780	1.039 (0.792–1.364)	0.335	0.762 (0.438–1.324)

^*Borrmann classification, TNM staging, lymph node metastasis, and depth of invasion were taken as covariables.

^aMedian survival time.

^bMean survival time.